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management versus medical therapy only.1 It is logical that
this would result in an increased interest in prophylactic CEA
and more carotid duplex examinations to screen for 60% to
99% ICA stenosis in asymptomatic patients. Indeed, since
publication of the ACAS in 1995, there has been an overall
increase in the number of CEAs performed for asympto-
matic disease.2-4 Most screening carotid duplex studies,
however, reveal < 60% ICA stenosis.5-12 Because progression
of ICA stenosis clearly identifies a patient cohort at higher
risk for stroke,5,13-15 duplex follow-up to detect progression
to 60%-99% ICA stenosis must be considered in asympto-
matic patients with < 60% ICA stenosis. Although several
recent studies have suggested the need for careful short-term
duplex follow-up in certain patient groups deemed to be at
higher risk for progression and stroke,5,7,14-16 the optimal
follow-up interval to detect progression from < 60% to 60%-
99% ICA stenosis remains unknown.
In a previous report from our institution, it was deter-
mined that ICAs with < 60% stenosis and peak systolic
The Asymptomatic Carotid Atherosclerosis Study
(ACAS) demonstrated a 53%, 5-year relative risk reduction
for ipsilateral stroke or death in asymptomatic patients with
60% to 99% internal carotid artery (ICA) stenosis treated
with carotid endarterectomy (CEA) and the best medical
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Objectives: The Asymptomatic Carotid Atherosclerosis Study established benefit of carotid endarterectomy for 60% to
99% asymptomatic internal carotid artery (ICA) stenosis. Optimal follow-up intervals to detect progression from < 60%
to 60%-99% ICA stenosis are unknown. In a previous study from our laboratory, we found that ICAs with < 60% steno-
sis and peak systolic velocities (PSVs) of 175 cm/s or more on initial duplex were at high risk for progression.
Prospective evaluation of this hypothesis and determination of optimal duplex follow-up intervals for asymptomatic
patients with < 60% ICA stenosis form the basis of this report.
Methods: All patients who underwent initial carotid duplex examination for any indication since January 1, 1995,
with at least one patent, asymptomatic, previously nonoperated ICA with < 60% stenosis; with 6 months’ or greater
follow-up; and with one or more repeat duplex examinations were entered into the study. On the basis of the ini-
tial duplex examination, ICAs were classified into two groups: those with a PSV less than 175 cm/s and those with
a PSV of 175 cm/s or more. Follow-up duplex examinations were performed at varying intervals to detect pro-
gression from < 60% to 60%-99% ICA stenosis with criteria previously reported (both PSV ≥ 260 cm/s and end-
diastolic velocity ≥ 70 cm/s).
Results: A total of 407 patients (640 asymptomatic ICAs with < 60% stenosis) underwent serial duplex scans (mean follow-
up, 22 months). Three ICAs (0.5%) became symptomatic and progressed to 60%-99% ICA stenosis at a mean of 21 months
(all transient ischemic attacks), whereas four other ICAs occluded without stroke during follow-up. Progression to 60%-
99% stenosis without symptoms was detected in 46 ICAs (7%) (mean, 18 months). Of the 633 patent asymptomatic arter-
ies, 548 ICAs (87%) had initial PSVs less than 175 cm/s, and 85 ICAs (13%) had initial PSVs of 175 cm/s or more.
Asymptomatic progression to 60%-99% ICA stenosis occurred in 22 (26%) of 85 ICAs with initial PSVs of 175 cm/s or
more, whereas 24 (4%) of 548 ICAs with initial PSVs less than 175 cm/s progressed (P < .0001). The Kaplan-Meier method
was used to determine freedom from progression at 6 months, 12 months, and 24 months, which was 95%, 83%, and 70%
for ICAs with initial PSVs of 175 cm/s or more versus 100%, 99%, and 95%, respectively, for ICAs with initial PSVs less
than 175 cm/s (P < .0001).
Conclusions: Patients with < 60% ICA stenosis and PSVs of 175 cm/s or more on initial duplex examination are sig-
nificantly more likely to progress asymptomatically to 60%-99% ICA stenosis, and progression is sufficiently frequent
to warrant follow-up duplex studies at 6-month intervals. Patients with < 60% ICA stenosis and initial PSVs less than
175 cm/s may have follow-up duplex examinations safely deferred for 2 years. (J Vasc Surg 2001;33:56-61.)
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velocities (PSVs) of 175 cm/s or more on initial duplex
examination were at high risk for progression to 60%-99%
stenosis.7 This study was carried out in a select group of
patients enrolled in our Homocysteine and Progression of
Atherosclerosis Study (HPAS).17 The HPAS is a prospec-
tive, longitudinal study of atherosclerotic disease progres-
sion in patients aged 40 to 80 years with documented
symptomatic peripheral arterial disease (history of claudi-
cation, ischemic rest pain, ulceration, gangrene, or previ-
ous infrainguinal bypass graft) or cerebrovascular disease
(transient ischemic attack [TIA], stroke, previous CEA).
In the current study, we prospectively apply duplex cri-
teria previously determined in the HPAS patient group to a
general patient population referred for carotid duplex exam-
ination in our university- and veteran’s hospital-based vas-
cular surgery practice. The purpose of this study was to
evaluate the hypothesis that asymptomatic patients with 
< 60% ICA stenosis and ICA PSVs of 175 cm/s or more on
initial duplex examination are at high risk for progression to
60%-99% ICA stenosis. A second objective was to determine
optimal duplex follow-up intervals to detect progression of
< 60% ICA stenosis to 60%-99% ICA stenosis.
METHODS
Patients. Patients who underwent initial carotid
duplex examination for any indication at the Oregon
Health Sciences University (OHSU) or the Portland
Veterans’ Affairs Medical Center (PVAMC) vascular labo-
ratories since January 1, 1995, with at least one patent,
asymptomatic, previously nonoperated ICA with < 60%
stenosis; one or more repeat carotid duplex examinations;
and 6 months’ or greater follow-up were included for
analysis of ICA progression. At the initial and follow-up
vascular laboratory visits, general demographic data,
including patient age, sex, and date and indication for
examination, were recorded by the examining vascular
technologist. A history of current or past tobacco use,
hypertension, coronary artery disease, diabetes mellitus,
and hyperlipidemia was noted. Any history of previous
arterial surgery, including contralateral CEA, percuta-
neous transluminal coronary angioplasty, coronary artery
bypass grafting, arterial inflow procedures, lower extrem-
ity bypass grafting, and abdominal aortic aneurysm repair,
was also recorded.
At follow-up visits patients with asymptomatic carotid
disease were considered to have become symptomatic if
focal, unilateral neurologic symptoms consistent with TIA
or stroke developed or if ocular symptoms consistent with
amaurosis fugax occurred. Patients with nonfocal symp-
toms such as ataxia, dizziness, blurry vision, and confusion
were considered asymptomatic with respect to their
carotid artery disease.
Duplex examinations and determination of 60% to
99% ICA stenosis. All carotid duplex examinations were
performed by registered vascular technologists at the vas-
cular laboratories of the Oregon Health Sciences
University and the Portland Veterans’ Affairs Medical
Center. At each examination, the common carotid artery
(CCA) PSV, ICA PSV, ICA end-diastolic velocity (EDV),
and ICA/CCA PSV ratios were determined for each
carotid artery. On the basis of data from the initial duplex
examination, ICAs were classified into two groups for sub-
sequent analysis: those with initial ICA PSVs of 175 cm/s
or more and those with initial ICA PSVs less than 175
cm/s. Intervals for follow-up duplex examination varied
according to the discretion of the patient’s referring physi-
cian or attending vascular surgeon.
Determination of the presence of 60% to 99% ICA
stenosis was based on criteria previously derived from
blinded comparison of 352 ICA angiograms and carotid
duplex scans from our institution and the University of
Washington.18 In that study, in accordance with ACAS
guidelines, the distal cervical ICA diameter was used as the
denominator in calculations of percent angiographic
stenosis. The highest overall accuracy for duplex detection
of 60% to 99% ICA stenosis was achieved with the combi-
nation of an ICA PSV of 260 cm/s or more and an ICA
EDV of 70 cm/s or more. These criteria have an overall
accuracy of 90%, a sensitivity of 84%, a specificity of 94%,
and a positive predictive value of 92% for determining 60%
to 99% ICA stenosis.18
Data analysis. Follow-up duplex examinations of ICAs
were analyzed for progression from < 60% ICA stenosis to
60%-99% ICA stenosis. Patients who progressed without
Table I. Comparison of risk factors in patients who did and did not progress from < 60% ICA stenosis to 60%-99%
ICA stenosis
Patients who did not progress (%) Patients who progressed (%)
Parameter n = 360 n = 41 P value
Male sex 75 75 .99
Hypertension 64 75 .15
Heart disease 52 60 .31
Diabetes 27 30 .7
Hyperlipidemia 32 35 .66
Smoking 76 72 .61
Previous arterial surgery 55 73 .03
Leg bypass 14 30 .01
Carotid endarterectomy 17 30 .07
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symptoms to 60%-99% ICA stenosis were compared with
those who did not progress to 60%-99% ICA stenosis and
remained asymptomatic. Patients who progressed and
those who did not were compared with respect to age, sex,
presence of atherosclerotic risk factors, and a history of pre-
vious vascular surgical procedures. Duplex parameters of
ICA PSV, ICA EDV, and ICA/CCA PSV ratios obtained
at initial duplex examination were compared between
patients who progressed to 60%-99% ICA stenosis and
those who did not. Comparison of ICAs with initial PSVs
of 175 cm/s or more and those with initial PSVs less than
175 cm/s determined the overall likelihood of progression
from < 60% ICA stenosis to 60%-99% ICA stenosis in each
group, as well as time to detection of progression, and free-
dom from progression at various follow-up intervals.
Data were collected and stored in Microsoft Access 97
database (Microsoft, Inc, Redmond, Wash). Statistical
analysis was performed with JMP version 3.1 statistical
software program (SAS Institute, Cary, NC). Associations
between categorical variables were analyzed with two-by-
two contingency tables where appropriate. Continuous
variables were evaluated with the Student t test. Risk fac-
tors associated with progression to 60%-99% ICA stenosis
were identified with univariate analysis and multivariate
logistic regression analysis. Kaplan-Meier curves of free-
dom from progression over time were compared by means
of the log-rank method. All statistical results were consid-
ered significant when the P value was less than .05.
RESULTS
Patients and arteries. A total of 407 patients with
640 patent, previously nonoperated, < 60% stenotic ICAs
were entered into the study. Patients were observed for a
mean of 22 months (range, 6-54 months) with a mean of
three examinations per patient (range, 2-10 examina-
tions). Both ICAs were available for analysis in 233
patients (57%). Only one ICA was evaluated in 174
patients (43%) because of contralateral occlusion (5%),
previous operation (19%), or contralateral ICA stenosis of
60% to 99% (19%).
Symptomatic progression. In follow-up, three
patients (0.7%) and three ICAs (0.5%) were noted to
develop hemispheric symptoms and ipsilateral progression
to 60%-99% ICA stenosis. Symptoms occurred at a mean
of 21 months, and clinically, all were TIAs. All three
patients underwent successful endarterectomy without
complication. One ICA (0.15%) in one patient (0.2%)
progressed to occlusion at 54 months and was associated
with a TIA but not a clinical stroke. No patient was
observed to have hemispheric symptoms without ipsilat-
eral progression of ICA stenosis.
Asymptomatic progression. Progression to 60%-99%
ICA stenosis without symptoms was detected in 41
patients (10%) and 46 ICAs (7%) at a mean of 18 months.
Three patients (0.7%) and three ICAs (0.5%) progressed
asymptomatically to occlusion at a mean of 16 months.
Sixteen patients (4%) subsequently underwent endarterec-
tomy of 17 ICAs (3%). No perioperative strokes or deaths
occurred.
Clinical risk factors. No differences were noted
between patients who progressed to 60%-99% ICA steno-
sis and those who did not with regard to male sex, hyper-
tension, coronary artery disease, diabetes mellitus,
hyperlipidemia, and smoking history (Table I). Seventy-
three percent of patients who progressed to 60%-99% ICA
stenosis had undergone previous arterial surgery, as
opposed to 55% of patients who did not progress (P =
.03). This difference was accounted for by the higher per-
centage of lower extremity bypass graft procedures previ-
ously performed in patients who progressed versus those
who did not (30% vs 14%, P = .01).
Initial duplex examination. Regardless of whether
the initial ICA PSV was less than 175 cm/s or 175 cm/s
or more, duplex parameters of ICA PSV, ICA EDV, and
ICA/CCA PSV ratio at the time of initial duplex exami-
nation were significantly higher in asymptomatic ICAs
that progressed to 60%-99% stenosis than in those that did
not progress (Table II). The mean initial ICA PSV in
arteries that progressed was 166 cm/s compared with the
mean initial ICA PSV of 110 cm/s in arteries that did not
progress (P < .0001). The mean initial ICA EDV (55
cm/s vs 36 cm/s, P < .0001) and mean initial ICA/CCA
PSV ratios (2.21 vs 1.40, P < .0001) were also higher in
patients who progressed than in those who did not.
Asymptomatic progression and initial ICA PSV. A
total of 548 ICAs (87%) had initial PSVs less than 175
cm/s, whereas 85 ICAs (13%) had initial PSVs of 175
cm/s or more. Asymptomatic progression from < 60% to
60%-99% ICA stenosis occurred in only 24 (4%) of 548
ICAs with initial PSVs less than 175 cm/s, whereas 22
(26%) of 85 ICAs with initial PSVs of 175 cm/s or more
progressed to 60%-99% stenosis (P < .0001, Fig 1). The
mean time to progression in asymptomatic ICAs with ini-
tial PSVs less than 175 cm/s was 21 ± 10 months com-
Table II. Comparison of initial duplex parameters in arteries progressing and not progressing from < 60% ICA stenosis
to 60%-99% ICA stenosis
Nonprogressing arteries Progressing arteries
Initial duplex value n = 587 n = 46 P value
Mean PSV 110 ± 47 166 ± 55 < .0001
Mean EDV 36 ± 15 55 ± 22 < .0001
Mean ICA/CCA PSV ratio 1.40 ± .68 2.21 ± 1.00 < .0001
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pared with 14 ± 9 months in those with initial PSVs of 175
cm/s or more (P = .01).
Kaplan-Meier curves to determine the probability of
freedom from progression to 60%-99% ICA stenosis  are
shown in Fig 2. For asymptomatic patients with < 60%
ICA stenosis and initial ICA PSVs less than 175 cm/s,
probability of freedom from progression to 60%-99% ICA
stenosis was 100% at 6 months, 99% at 1 year, and 95% at
2 years. In asymptomatic patients with < 60% ICA steno-
sis and initial ICA PSVs of 175 cm/s or more, the proba-
bility of freedom from progression to 60%-99% ICA
stenosis was 95% at 6 months, 83% at 1 year, and 70% at 2
years (P < .0001 for all intervals).
In a multivariate logistic regression analysis, the influ-
ence of sex, hypertension, coronary artery disease, dia-
betes, hyperlipidemia, smoking, peripheral vascular disease,
contralateral carotid occlusion, contralateral ICA stenosis
of 60% to 99%, and an initial ICA PSV of 175 cm/s or
more was evaluated. The only factor significantly associated
with progression from < 60% ICA stenosis to 60%-99%
ICA stenosis was an initial ICA PSV of 175 cm/s or more
(P < .0001; odds ratio, 5.8; 95% CI, 2.8-11.9).
DISCUSSION
The findings of ACAS have resulted in controversy
regarding the use of duplex ultrasonography as a screening
tool to identify patients with asymptomatic ICA stenosis
of 60% to 99% who may benefit from prophylactic CEA.
Carotid duplex screening examinations have been shown
to be cost-effective when factors such as age, risk of stroke,
cost of examinations, and quality-adjusted life years are
considered.19 Screening examinations may be particularly
useful in certain high-risk subgroups with an increased
prevalence of carotid disease.20
A higher prevalence of significant ICA stenosis has been
noted in patients with known peripheral arterial occlusive
disease, aortoiliac occlusive disease, or abdominal aortic
aneurysm.6,9,12 Gentile et al6 screened 225 patients who
had no prior carotid surgery, carotid arteriography, or cere-
brovascular symptoms before infrainguinal bypass grafting
and noted ≥ 50% ICA stenosis or occlusion in 28.4% of
patients. Similar findings were reported by Marek et al12
who screened 188 patients with claudication and detected 
≥ 50% ICA stenosis in 21.8% of patients. In another study
by Cahan et al,9 ≥ 50% ICA stenosis was found in 26.7% of
patients screened with carotid duplex before aortic recon-
struction for aortoiliac occlusive disease or abdominal aortic
aneurysm. However, Meissner et al8 performed carotid
duplex studies in 567 patients randomly selected from the
population. In this group of patients not preselected by the
presence of known atherosclerotic disease, only 8% of
patients had ≥ 50% ICA stenosis, emphasizing the critical
importance of the population selected for screening.
In three recent studies of the natural history of ICA
stenosis, an association has found between progression of
carotid stenosis and occurrence of TIA or stroke.14-16
Muluk et al14 studied 1004 patients (1701 ICAs) and
noted an increased frequency of ipsilateral neurologic
events (TIA, amaurosis fugax, and stroke) in patients with
progression from < 50% ICA stenosis to ≥ 50% ICA steno-
sis, or an increase to a higher category of stenosis if the
baseline ICA stenosis was ≥ 50%. In a study of 344 male
veterans, Mansour et al16 identified an increase risk of
stroke in patients who progressed from 50%-79% ICA
stenosis to 80%-99% stenosis. This association was also
noted by Rockman et al15 in a retrospective study of 425
patients with 50%-79% ICA stenosis.
Although progression of carotid disease is clearly associ-
ated with an increased risk of neurologic symptoms, most
detected carotid stenosis is asymptomatic, and most progres-
sion of ICA stenosis is also asymptomatic. If one performs
prophylactic CEA according to the ACAS guidelines and
when first encountered most asymptomatic patients have 
< 60% ICA stenosis, then variables need to be identified to
determine which patients with < 60% ICA stenosis are most
likely to progress without symptoms to 60%-99% ICA steno-
sis. In addition, guidelines for vascular laboratory follow-up
are required to minimize negative follow-up studies.
In a previous “hypothesis-seeking” study in patients
with symptomatic vascular disease from our institution,7
Fig 1. Asymptomatic progression from < 60% to 60%-99% ICA stenosis based on initial ICA PSV. Excluded are seven ICAs that became
symptomatic and/or progressed to occlusion.
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we found hypertension and decreased ankle/brachial
index to be marginal predictors of asymptomatic progres-
sion from < 60% ICA stenosis to 60%-99% ICA stenosis.
The strongest predictor of progression from < 60% to
60%-99% ICA stenosis was an ipsilateral ICA PSV of 175
cm/s or more at the time of initial duplex examination. In
the current prospective study, we sought to determine, in
a more generalized vascular laboratory population, if
patients with ICA PSVs of 175 cm/s or more at initial
duplex examination were indeed at higher risk for pro-
gression asymptomatically from < 60% ICA stenosis to
60%-99% ICA stenosis. Progression from < 60% ICA
stenosis to 60%-99% ICA stenosis was noted in 26% of
ICAs with initial PSVs of 175 cm/s or more versus only
4% of ICAs with initial PSVs less than 175 cm/s (P <
.0001), confirming our original hypothesis.
Analysis of the Kaplan-Meier curves derived from the
data presented here suggests that asymptomatic ICAs with
< 60% stenosis and initial PSVs of 175 cm/s or more have
a 5% rate of progression to 60%-99% ICA stenosis in the
first 6 months after the initial examination. At the 12-
month interval, another 12% of ICAs in this cohort exhib-
ited progression from < 60% to 60%-99% ICA stenosis.
With regard to the establishment of vascular laboratory
follow-up recommendations, patients with < 60% ICA
stenosis and ICA PSVs of 175 cm/s or more on their ini-
tial duplex examination progress to 60%-99% ICA stenosis
with sufficient frequency to warrant duplex follow-up at 6-
month intervals, if they remain candidates for prophylactic
CEA. Conversely, in ICAs with < 60% stenosis and initial
PSVs less than 175 cm/s, a 5% prevalence of progression
to 60%-99% ICA stenosis was not noted until 2 years after
the initial duplex examination, with only an additional 4%
progressing in the next year. Therefore, patients with 
< 60% ICA stenosis and ICA PSVs less than 175 cm/s on
their initial duplex study who remain asymptomatic and
continue to be candidates for prophylactic CEA may have
follow-up duplex studies delayed for at least 2 years. These
recommendations should prove useful to practicing physi-
cians when scheduling asymptomatic patients with < 60%
ICA stenosis for follow-up carotid duplex examinations.
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Dr J. Dennis Baker (Los Angeles, Calif). I enjoyed your paper
because it addresses the question of how often should we be car-
rying out these examinations. Most of the recommendations have
been based on gut feelings rather than analysis. We really have to
repeat these studies in other settings to validate your conclusions.
Currently, the payment policy that Medicare has instituted in the
western states, including Oregon, calls for a minimum of a 1-year
interval on follow-up of asymptomatic patients with < 60% steno-
sis. If we want to change the Medicare guidelines, we’re going to
have to have a lot more published evidence from different groups.
Thank you. 
Dr Todd D. Lovelace. Thank you for those comments, Dr
Baker. Hopefully, we’ve been able to shed some light on who is
at higher risk for progression and who is not. 
Dr Gary M. Gross (Huntsville, Ala). If I understand this right,
you’ve excluded all the patients who had a study at less than 6
months or who became symptomatic. If so, I wonder how can
you recommend we wait 6 months or longer when we really don’t
know anything about what happened to any of the patients who
were studied at less than 6 months. Some of the excluded patients
may have developed severe stenosis or carotid occlusion, requir-
ing treatment. Do you know what happened to the excluded
patients, as far as developing neurologic symptoms, stroke, or
some other reason for nonelective repair ultrasound exam? 
Dr Lovelace. We did study patients who had duplex examina-
tions less than 6 months, but we didn’t include those patients in
the analysis, mainly because almost all these patients had minimal
disease and it does take a period of time for these patients to
progress. Since they’re all asymptomatic and all have minimal dis-
ease, it takes quite a while for any progression to occur. 
Dr Gross. But do you think, based on your results, that you
can make a recommendation to wait 6 months when you really
don’t know what happened up to 6 months? 
Dr Lovelace. That’s a very important point. The first study by
our group in the patients enrolled in our homocysteine study, in
which the duplex examinations were performed at specific inter-
vals, gave us information to determine whether or not we should
look at the first 6-month period as a determination of follow-up.
In that study virtually no progression occurred before the first 6-
month interval. Therefore, in this study we chose to have at least
6 months of follow-up as a criterion for inclusion in the study. 
Dr D. Eugene Strandness (Seattle, Wash). I can answer Dr
Gross’ question in part from our Seattle experience. We looked at
over 200 patients followed for 10 years with a study done every 6
months regardless of the degree of disease, except for the 80% to
99%. The patients with a less than 50% diameter reduction did not
go on to an occlusion, and they progressed very slowly. They
require a follow-up exam only once a year. Once you get past the
50% marker and, as you have shown, beyond the 60% mark, our
data and yours would suggest that a 6-month follow-up period is
what should be carried out. 
Dr Lovelace. Thank you, Dr Strandness.
Dr Jack L. Cronenwett (Lebanon, NH). Todd, from my
simplistic approach, what you’ve shown us today is that lesions
that are closer to 60% when detected exceed 60% more rapidly.
Is this correct? 
Dr Lovelace. Correct. 
Dr Cronenwett. My question, though, is that you’ve talked
about progression rates. I realize it’s difficult to look at incre-
mental stenoses less than 50%, but can you tell us whether lesions
that begin at very low percentages progress less rapidly or more
rapidly than lesions as they approach 60%? 
Dr Lovelace. I think it is true that with minimal amounts of
stenosis, progression rates to > 60% stenosis are very slow.
Perhaps grouping the arteries according to ranges of peak systolic
velocities such as < 80 cm/s, < 120 cm/s, < 150 cm/s, etc, would
have been a useful subanalysis to address your question, but we
did not do that in this study.
Dr Cronenwett. Excuse me, but I think you’re using “pro-
gression” here to mean achieving 60% stenosis, not the rate of
diameter change.
Dr Lovelace. Correct. We did not specifically look at the rate
of change in the arteries, only the rate of reaching the specific 
≥ 60% threshold.
DISCUSSION
